Academic Journal
Q2BMC Cancer
About BMC Cancer
BMC Cancer is a scholarly journal published by BioMed Central Ltd. SCImago 2025 places it in Q2 with an SJR of 1.172 and an H-index of 180.
Its listed coverage is 2001-2026 and its research categories include Cancer Research (Q2); Genetics (Q2); Oncology (Q2). The 2025 dataset reports 1902 documents and 17143 citations across the latest three-year reporting window.
Journal Metrics
Metrics can change by reporting year. Verify time-sensitive values with the publisher or indexing service.
Aims & Scope
The journal publishes research related to Cancer Immunotherapy and Biomarkers, Ferroptosis and cancer prognosis, Breast Cancer Treatment Studies, Cancer survivorship and care, Global Cancer Incidence and Screening, Cancer Cells and Metastasis.
Recent Research Articles
Latest publications matched automatically by ISSN.
Development and internal validation of machine learning-based prognostic prediction models for radical gastrectomy: a multidimensional risk stratification study
Jun Wu, Luqing Zhou, Haidi Chang, Tian Qin et al.
2026-09-10 · DOI: 10.1186/s12885-026-16964-6NNMT-associated metabolic–thromboinflammatory–immune co-activation in heterogeneous CTC clusters: a hypothesis-generating computational framework”
Jiayang Gong, Zhe Wang, Yun Shi, Minlan Ren et al.
2026-09-10 · DOI: 10.1186/s12885-026-16692-xEnhancing prediction of pathological complete response to neoadjuvant immunotherapy in non-small cell lung cancer by whole-lung radiomics
Xiaoting Cai, Jingyi Yang, Jiahui E, Dianzhe Wang et al.
2026-09-10 · DOI: 10.1186/s12885-026-16939-7Patients’ and oncologists’ perspectives on shared decision-making and treatment communication in HR+/HER2 − advanced breast cancer: a multicountry survey
Alessandra Fabi, Andrea Botticelli, Saverio Cinieri, Gilles Freyer et al.
2026-09-10 · DOI: 10.1186/s12885-026-16578-yShikonin as a Parkin-dependent hypoxia-selective agent against triple-negative breast cancer identified by machine learning
Zichen Niu, Xuegang Niu
2026-09-10 · DOI: 10.1186/s12885-026-16675-yGenomic alterations and co-mutation patterns in advanced NSCLC: a real-world DNA-based NGS study in a large Turkish cohort
Aysu Sadioglu, Ozgur Ekinci, Nalan Akyurek
2026-09-10 · DOI: 10.1186/s12885-026-16949-5Quality of life symptom burden heterogeneity in papillary thyroid cancer survivors: latent profiles and the mediating role of decision regret
Juan Deng, Hongyu Xiang, Qin Deng, Zhihui Chen et al.
2026-09-10 · DOI: 10.1186/s12885-026-16922-2Targeted agents combined with immune checkpoint inhibitors in advanced non-small cell lung cancer: a systematic review and externally anchored Bayesian network meta-analysis
Jianxiong Kang, Jianhong Zhou, Shenjie Yang
2026-09-10 · DOI: 10.1186/s12885-026-16833-2Assessment of long-term complications in adult oncology patients with superior vena cava syndrome receiving tunneled femoral inserted central catheters: a prospective cohort study
Zhen-Ming Wu, Chun-Li Huang, Ze-Yin Hu, Meng-Na Luo et al.
2026-09-09 · DOI: 10.1186/s12885-026-16444-xTumor cell proliferation by mitotic count and Ki67 in prognostication and subclassification of hormone receptor-positive breast cancer
Gøril Knutsvik, Ingunn M. Stefansson, Sura Aziz, Tor Audun Klingen et al.
2026-09-09 · DOI: 10.1186/s12885-026-16925-zAssociation of rituximab with survival outcomes in primary testicular diffuse large B-cell lymphoma: a systematic review and meta-analysis of retrospective studies
Kaiyue Liu, Zhihe Liu, Yuhang Zhang, Wenqiu Wang et al.
2026-09-09 · DOI: 10.1186/s12885-026-16658-zA SORT1-associated transcriptional signature links adipogenic plasticity, stemness and drug-resistance programs in 3D glioblastoma spheroids: dissection of ligand-dependent and ligand-independent arms
Abdallah Fallah, Alain Zgheib, Bogdan Alexandru Danalache, Nicoletta Eliopoulos et al.
2026-09-09 · DOI: 10.1186/s12885-026-16856-9Locoregional and distant recurrence after neoadjuvant chemoimmunotherapy versus chemoradiotherapy in esophageal squamous cell carcinoma: a focused meta-analysis
Yingding Ruan, Wenjun Cao, Chuan Long, Changjiang Li et al.
2026-09-09 · DOI: 10.1186/s12885-026-16944-wPreoperative MRI radiomics predicts IL13Rα2 expression and survival in glioblastoma
Yusong Zhang, Jiajun He, Donghao Qin, Jiawei Hao et al.
2026-09-09 · DOI: 10.1186/s12885-026-16861-yComment on “Life’s essential 8 and specific cancer risk and mortality in men and women: a population-based cohort analysis of 332,417 United Kingdom participants” and the inclusion of sleep in cancer focused guidelines
Charlie Zhong, Sidney M Donzella, Erika Rees-Punia
2026-09-09 · DOI: 10.1186/s12885-026-16941-zMachine learning-based prediction of prolonged air leak after video-assisted thoracoscopic anatomical lung resection in older patients using cardiopulmonary exercise testing: a dual-centre development and validation study
Zixiao Wang, Kai Wang, Naiyue Zhu, He liu et al.
2026-09-09 · DOI: 10.1186/s12885-026-16933-zCorrection to: UBR-box containing protein, UBR5, is overexpressed in human lung adenocarcinoma and is a potential therapeutic target
Kumar Saurabh, Parag P. Shah, Mark A. Doll, Leah J. Siskind et al.
2026-09-09 · DOI: 10.1186/s12885-026-16955-7Analysis of hematologic toxicity profiles following CAR-T cell therapy: a retrospective cohort study
Henan Wang, Xindi Liu, Fuli Li, Yuanzheng Liang et al.
2026-09-09 · DOI: 10.1186/s12885-026-16932-0Clinicopathological characteristics of synchronous bilateral breast cancer compared to unilateral breast cancer: a propensity score-matched analysis
Yena Yoon, Eun-Kyu Kim, Kyung-Hwak Yoon, Hyoung Won Koh et al.
2026-09-09 · DOI: 10.1186/s12885-026-16942-yTime to benefit of perioperative immunotherapy among patients with resectable non-small-cell lung cancer
Yongyan Lu, Wenming Bian, Xiaohui Jia, Jingyi Li et al.
2026-09-08 · DOI: 10.1186/s12885-026-16662-3Reviews
Community Reviews
Version History
September 8, 2026 at 12:08 am
September 8, 2026